What is the recommended treatment for sinus infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Bacterial Sinusitis

For most adults with acute bacterial sinusitis, start with amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days, as this provides optimal coverage against resistant organisms including β-lactamase-producing bacteria. 1

Initial Diagnostic Considerations

Before initiating antibiotics, distinguish between viral and bacterial sinusitis:

  • Viral rhinosinusitis (the common cold) is the most common cause and does not require antibiotics 2
  • Bacterial sinusitis should be suspected when symptoms persist beyond 10 days without improvement, or when severe symptoms (high fever ≥39°C with purulent nasal discharge) occur for 3-4 consecutive days, or when symptoms worsen after initial improvement 3
  • Watchful waiting for 7 days without antibiotics is appropriate for uncomplicated cases in adults when follow-up can be assured, starting antibiotics only if no improvement occurs 1

First-Line Antibiotic Selection

Standard Adult Dosing

Amoxicillin-clavulanate is preferred over plain amoxicillin because β-lactamase-producing H. influenzae and M. catarrhalis have become increasingly prevalent, and the clavulanate component provides essential coverage against these organisms 1, 3

  • Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days 1
  • Plain amoxicillin 500-875 mg twice daily remains acceptable only for uncomplicated cases without recent antibiotic exposure 1
  • Treatment duration: 5-10 days, with most guidelines recommending continuation until symptom-free for 7 days 1
  • Shorter 5-7 day courses have comparable efficacy with fewer side effects 1

Pediatric Dosing

  • High-dose amoxicillin 80-90 mg/kg/day in 2 divided doses for areas with high prevalence of resistant S. pneumoniae 1
  • Amoxicillin-clavulanate 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses for children with risk factors (age <2 years, daycare attendance, recent antibiotic use) 1

Penicillin-Allergic Patients

Second- and third-generation cephalosporins are the preferred alternatives, as the risk of cross-reactivity in penicillin-allergic patients is negligible 1

Recommended Cephalosporins

  • Cefuroxime-axetil (second-generation) 1
  • Cefpodoxime-proxetil (third-generation, superior activity against H. influenzae) 1
  • Cefdinir (third-generation, excellent coverage) 1
  • For pediatric penicillin allergy: cefpodoxime proxetil 8 mg/kg/day in two doses 1

Critical Pitfall to Avoid

Never use azithromycin or other macrolides as first-line therapy due to 20-25% resistance rates among S. pneumoniae and H. influenzae 1

Treatment Failure Protocol

Reassess at 72 hours (pediatrics) or 3-5 days (adults) if no improvement occurs 1

Second-Line Options

When first-line therapy fails or for complicated sinusitis:

  • Respiratory fluoroquinolones: Levofloxacin 500-750 mg once daily or moxifloxacin 1, 4
  • Fluoroquinolones provide 90-92% predicted clinical efficacy and 100% microbiologic eradication of S. pneumoniae, including multi-drug resistant strains 1
  • Reserve fluoroquinolones specifically for treatment failures, complicated sinusitis (frontal, ethmoidal, or sphenoidal involvement), or multi-drug resistant organisms to prevent resistance development 1

Anatomic Location-Based Treatment

Maxillary Sinusitis (Most Common)

  • Standard first-line antibiotics (amoxicillin-clavulanate) 1
  • Symptoms: unilateral/bilateral infraorbital pain worsening when bending forward, pulsatile, peaking evening/night 1

Frontal, Ethmoidal, or Sphenoidal Sinusitis

  • Consider fluoroquinolones (levofloxacin or moxifloxacin) due to potential for serious complications 1

Adjunctive Therapies

Intranasal Corticosteroids

  • Recommended as adjunct to antibiotic therapy in both acute and chronic sinusitis 2, 1
  • Continue for 3 months when cough disappears with therapy 2

Oral Corticosteroids

  • Short-term use (e.g., dexamethasone 4 mg) may be beneficial for acute hyperalgic sinusitis (severe pain) or marked mucosal edema 1
  • Should never be used as monotherapy; always combine with appropriate antibiotics 1

Decongestants

  • Oxymetazoline hydrochloride for 5 days maximum 2
  • No prospective randomized trials prove efficacy of nasal or oral decongestants, but clinical experience supports their use 2

Supportive Measures

  • Adequate hydration, analgesics, warm facial packs, sleeping with head elevated 1

Critical Pitfalls to Avoid

  1. Inadequate treatment duration leads to relapse - ensure minimum 5 days, typically 7-10 days total 1
  2. Overuse of fluoroquinolones promotes resistance - reserve for treatment failures or complicated cases 1
  3. Failure to reassess at appropriate intervals - check at 72 hours (pediatrics) or 3-5 days (adults) 1
  4. Using macrolides as first-line therapy - resistance rates are too high 1
  5. Stopping antibiotics when symptoms improve - complete the full course to prevent relapse 1

When to Refer to Specialist

  • Sinusitis refractory to usual antibiotic treatment 1
  • Recurrent sinusitis (≥3 episodes per year) 1
  • Need to clarify allergic or immunologic basis 1
  • Documented chronic sinus infection with anatomic obstruction amenable to endoscopic sinus surgery 2

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.